Focal One’s Post

Introducing the Wealthing VC Fund’s newest investment Avenda Health. The company is revolutionizing precision prostate cancer evaluation and management with the power of deep learning. Their cutting-edge software utilizes advanced 3D mapping to provide physicians with precise insights, empowering them to make confident and informed care decisions. Introducing Avenda's Unfold AI, enabling urologists to achieve unprecedented visibility on tumor size and location. With this groundbreaking technology, tumor ablation can now serve as a viable alternative to traditional surgery, promising superior outcomes and significantly reduced complications for patients. Avenda's innovative solution is not only effective but also cost-efficient, with a 30-minute visit priced significantly less than traditional surgeries. By leveraging this technology, doctors can treat up to 5 times more patients and administer therapeutics directly from their office, eliminating the need for complex operating room procedures. Redefining prostate cancer care and set new standards for precision and accessibility in the field of urology. Together, let's pave the way for a brighter and healthier future. #prostatecancer #cancer #urology #healthcare #technology

Focal One sheds light on Movember this month by encouraging informed discussions about men’s health. 1 in 8 men Will be diagnosed with prostate cancer in their lifetime. It's essential to raise awareness and research treatment options. Check out the link to learn about the leading non-invasive prostate treatment, Focal One Robotic Focal HIFU. https://focalone.com/ #Cancer | #RoboticSurgery | #Urology | #ProstateCancer | #MedTech | #Movember

A study published in The Lancet Oncology shows that AI-assisted mammography screening can increase breast #cancer detection by 20% compared to human #doctors. In addition to improving early detection rates, AI also reduces #radiologists’ workloads by 44%. 🤓Here's the link to the original study: https://hubs.li/Q01-XLGv0 To learn more about the current state of AI in #radiology, read this CNN Health article: https://hubs.li/Q01-XPx10

#CancerCareDay #ECR2024 #SiemensHealthineers 📢 Don't miss Prof. Nicola Sverzellati's session at the Lung Cancer Symposium! The Professor of Radiology at the University of Parma, Italy, will lead an informative session at our upcoming symposium. Learn about 'Understanding Your Lung-RADS Score,' including the Lung-RADS 2022 categories, novel additions, and management of both benign and malignant nodules. ➡ https://lnkd.in/eDV-6c3C

Congratulations to Dr. Ahmed Gamal for winning first prize for the best paper at the Uro-Oncology 2024 conference in São Paulo, Brazil, held earlier this week. We greatly value our collaboration with Dr. Vipul Patel and his team at Advent Health, in validating our AI-enabled multi-spectral autofluorescence imaging technology for cancer detection in Robotic Assisted Radical Prostatectomy. This innovative technology holds immense potential in aiding accurate and efficient intraoperative cancer detection and enhanced visualization.   As we look towards the future, we continue with passion and determination in pushing the boundaries to improve patient outcomes.   #UroOnco24 #CytoVeris #Cancersurgery #AI #AdventHealth #Labelfree #Advancedvisualization #ProstateCancer #RARP #Precisionsurgery #CTInnovations #Urology #Oncology #medtech #cancerdetection #enhancedimaging #roboticsurgery #autofluorescence #cancermargin #multispectral #intraoperativeimaging #innovationinhealthcare

Congratulations to Dr. Mehran Movassaghi, #ProvSaintJohns Men’s Health Center director and urologist, who recently completed his 100th high-intensity focused ultrasound (HIFU) procedure. #HIFU therapy is a non-invasive and highly effective outpatient procedure for early-stage prostate cancer. This innovative procedure preserves part of the prostate, potentially helping men retain better erectile function and urinary control following treatment. With the Focal One® HIFU Robotic System, Dr. Movassaghi uses HIFU technology and image-guided fusion software to scan the entire #prostate structure and draw a precise contour around the affected prostate tissue. Then, he precisely targets and destroys tumor cells — preserving healthy surrounding tissues while customizing the procedure for each patient’s clinical condition. To learn more about our innovative men’s health care, visit https://lnkd.in/g-sUp7KU. #ProstateCancer #Urology #MensHealth #RoboticSurgery #PatientOutcomes

Our fund invested in Focal 1 five years ago. This med tech if valued like privately owned Insightech would probably have a market cap at least 6 times higher. Non invasive surgery is a major breakthrough for patients as they can be treated day in day out and a significant source of savings for social security and medical insurance. A must own in a portfolio for future mega capital gains

Education is the first step towards healing and prevention. Let’s take that step today on World Tumor Day by learning and sharing knowledge about tumors. . . #worldbraintumorday #braintumourawareness #cancer #braincancer #braintumor #tumour #arnicahealthtechcollege #ahtcollege #paramedicalcourses #radiology #healthtech #education #educational

🔶The integration of AIR Recon DL and high b-value diffusion-weighted imaging (DWI) for prostate MRI enhances the ability to visualize and characterize prostate lesions. Focus DWI GE HDXt 1.5T #MR30 🔷High b-value DWI generates more comprehensive images of the prostate gland and adjacent tissues, resulting in improved detection and staging of prostate cancer. Furthermore, it facilitates the differentiation between benign and malignant lesions, which can be challenging to differentiate using Conventional MRI techniques. #mri #prostate #radiology #medicalimaging

Dr. Amy Fowler, a radiologist and active researcher with the UW Carbone Cancer Center, is studying how a targeted imaging agent, tracked by positron emission tomography (PET) and magnetic resonance imaging (MRI) scans, can be used to observe the effectiveness of hormone #therapy given before #surgery. “The overall focus of this study is to better identify the cancers that are truly hormone sensitive versus those that may be hormone therapy resistant, and that helps in selecting a different treatment,” she said. Fowler hopes this imaging technique can eventually become standard for clinical use as a less-invasive alternative to using needle biopsies to track #treatment progress. Article: 'Clinical trial looks to improve treatment of early-stage #breastcancer' https://lnkd.in/gY82hHfg via UW Health #university #Wisconsin #cancer #clinicaltrials #clinicalresearch